Arcadia Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,537 | $1,306 | $1,255 | $1,170 |
Gross Profit | 505 | 673 | 435 | 500 |
EBITDA | -1,753 | -1,986 | -2,975 | -3,033 |
EBIT | -1,760 | -2,020 | -3,203 | -3,076 |
Net Income | -1,612 | 1,061 | -2,423 | -2,853 |
Net Change In Cash | 1,537 | 1,306 | 1,255 | 1,170 |
Free Cash Flow | 248 | -2,459 | -3,223 | -4,196 |
Cash | 3,936 | 5,504 | 3,317 | 6,518 |
Basic Shares | 1,363 | 1,362 | 1,361 | 1,285 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,330 | $9,956 | $6,780 | $8,034 |
Gross Profit | 2,030 | 154 | -1,928 | 2,835 |
EBITDA | -13,578 | -13,647 | -23,267 | -5,441 |
EBIT | -13,865 | -15,010 | -24,311 | -6,103 |
Net Income | -13,981 | -15,612 | -16,134 | -6,026 |
Net Change In Cash | 5,330 | 9,956 | 6,780 | 8,034 |
Cost of Revenue | 7,626 | |||
Free Cash Flow | -15,299 | -14,049 | -26,875 | -32,553 |
Cash | 6,518 | 20,644 | 28,685 | 14,042 |
Basic Shares | 1,236 | 599 | 532 | 248 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.87 |
2024-06-30 | $0.78 |
2024-03-31 | -$1.78 |
2023-12-31 | -$2.52 |
